Abstract
Adipose tissue contribution to body mass ranges from 6% in male athletes to over 25% in obese men and over 30% in obese women. Crosstalk between adipocytes and cancer cells that exist in close proximity can lead to changes in the function and phenotype of both cell types. These interactions actively alter the tumour microenvironment (TME). Obesity is one of the major risk factors for multiple types of cancer, including breast cancer. In obesity, the increase in both size and number of adipocytes leads to instability of the TME, as well as increased hypoxia within the TME, which further enhances tumour invasion and metastasis. In this chapter, we will discuss the diverse aspects of adipocytes and adipocyte-derived factors that affect the TME as well as tumour progression and metastasis. In addition, we discuss how obesity affects the TME. We focus primarily on breast cancer but discuss what is known in other cancer types when relevant. We finish by discussing the studies needed to further understand these complex interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Place AE, Jin Huh S, Polyak K (2011) The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res 13:227. https://doi.org/10.1186/bcr2912
Sundaram S, Johnson AR, Makowski L (2013) Obesity, metabolism and the microenvironment: links to cancer. J Carcinog 12:19. https://doi.org/10.4103/1477-3163.119606
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559–1564. https://doi.org/10.1126/science.1203543
Wu Y, Sarkissyan M, Vadgama J (2016) Epithelial-mesenchymal transition and breast cancer. J Clin Med 5:13. https://doi.org/10.3390/jcm5020013
Lee Y, Jung WH, Koo JS (2015) Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells. Breast Cancer Res Treat 153:323–335. https://doi.org/10.1007/s10549-015-3550-9
Ritter A, Friemel A, Fornoff F et al (2015) Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells. Oncotarget 6:34475–34493. https://doi.org/10.18632/oncotarget.5922
Ogunwobi OO, Liu C (2011) Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis 28:721–731. https://doi.org/10.1007/s10585-011-9404-x
Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19:156–172. https://doi.org/10.1038/cr.2009.5
Moreno-Bueno G, Portillo F, Cano A (2008) Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27:6958–6969. https://doi.org/10.1038/onc.2008.346
Thiery JP, Lim CT (2013) Tumor dissemination: an EMT affair. Cancer Cell 23:272–273. https://doi.org/10.1016/j.ccr.2013.03.004
Battula VL, Evans KW, Hollier BG et al (2010) Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28:1435–1445. https://doi.org/10.1002/stem.467
Mani SA, Guo W, Liao M-JJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715. https://doi.org/10.1016/j.cell.2008.03.027
Ota I, Li X-Y, Hu Y, Weiss SJ (2009) Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc Natl Acad Sci 106:20318–20323. https://doi.org/10.1073/pnas.0910962106
Chavey C, Mari B, Monthouel M-N et al (2003) Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278:11888–11896. https://doi.org/10.1074/jbc.M209196200
Tsai JH, Yang J (2013) Epithelial – mesenchymal plasticity in carcinoma metastasis. Genes Dev 27:2192–2206. https://doi.org/10.1101/gad.225334.113.2192
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428
Drake JM, Strohbehn G, Bair TB et al (2009) ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol Biol Cell 20:2207–2217. https://doi.org/10.1091/mbc.E08-10-1076
Gupta GP, Nguyen DX, Chiang AC et al (2007) Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765–770. https://doi.org/10.1038/nature05760
Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580–584. https://doi.org/10.1126/science.1228522
Hüsemann Y, Geigl JB, Schubert F et al (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13:58–68. https://doi.org/10.1016/j.ccr.2007.12.003
Yao D, Dai C, Peng S (2011) Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 9:1608–1620. https://doi.org/10.1158/1541-7786.MCR-10-0568
Xie H, Liao N, Lan F et al (2017) 3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition. Int J Mol Med 41:1385–1396. https://doi.org/10.3892/ijmm.2017.3336
Jie X-X, Zhang X-Y, Xu C-J et al (2017) Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: mechanisms and clinical applications. Oncotarget 8:81558–81571. https://doi.org/10.18632/oncotarget.18277
Zhou XD, Agazie YM (2008) Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells. Cell Death Differ 15:988–996. https://doi.org/10.1038/cdd.2008.54
Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9:179. https://doi.org/10.1186/1476-4598-9-179
Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69:7135–7139
Wells A, Yates C, Shepard CR (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 25:621–628. https://doi.org/10.1007/s10585-008-9167-1
Guaita-Esteruelas S, Gumà J, Masana L, Borràs J (2018) The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5. Mol Cell Endocrinol 462:107–118. https://doi.org/10.1016/J.MCE.2017.02.002
Vandeweyer E, Hertens D (2002) Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat 184:181–184. https://doi.org/10.1016/S0940-9602(02)80016-4
Duong MN, Geneste A, Fallone F et al (2017) The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance. Oncotarget 8:57622–57641. https://doi.org/10.18632/oncotarget.18038
Nieman KM, Romero IL, Van Houten B, Lengyel E (2013) Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta Mol Cell Biol Lipids 1831:1533–1541. https://doi.org/10.1016/j.bbalip.2013.02.010
Divella R, De Luca R, Abbate I et al (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7:2346–2359. https://doi.org/10.7150/jca.16884
Ribeiro RJT, Monteiro CPD, Cunha VFPM et al (2012) Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile. Cell Physiol Biochem 29:233–240. https://doi.org/10.1159/000337604
Nieman KM, Kenny HA, Penicka CV et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498–1503. https://doi.org/10.1038/nm.2492
Abramczyk H, Surmacki J, Kopeć M et al (2015) The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures: MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue. Analyst 140:2224–2235. https://doi.org/10.1039/c4an01875c
Zoico E, Darra E, Rizzatti V et al (2018) Role of adipose tissue in melanoma cancer microenvironment and progression. Int J Obes 42:344–352. https://doi.org/10.1038/ijo.2017.218
Berry DC, Stenesen D, Zeve D, Graff JM (2013) The developmental origins of adipose tissue. Development 140:3939–3949
Peinado JR, Pardo M, de la Rosa O, Malagón MM (2012) Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Proteomics 12:607–620. https://doi.org/10.1002/pmic.201100355
Morton GJ, Cummings DE, Baskin DG et al (2006) Central nervous system control of food intake and body weight. Nature 443:289–295. https://doi.org/10.1038/nature05026
Guyenet SJ, Schwartz MW (2012) Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab 97:745–755. https://doi.org/10.1210/jc.2011-2525
Iikuni N, Lam QLK, Lu L et al (2008) Leptin and inflammation. Curr Immunol Rev 4:70–79. https://doi.org/10.2174/157339508784325046
Ray A, Nkhata KJ, Cleary MP (2007) Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30:1499–1509
Jardé T, Caldefie-Chézet F, Damez M et al (2008) Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma. Oncol Rep 19:905–911
Mullen M, Gonzalez-Perez RR (2016) Leptin-induced JAK/STAT signaling and cancer growth. Vaccine 4:26. https://doi.org/10.3390/vaccines4030026
Nepal S, Kim MJ, Hong JT et al (2015) Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axis. Oncotarget 6:7166–7181. https://doi.org/10.18632/oncotarget.3347
Zheng Q, Banaszak L, Fracci S et al (2013) Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer 20:797–808. https://doi.org/10.1530/ERC-13-0329
Stern JH, Rutkowski JM, Scherer PE (2016) Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab 23:770–784. https://doi.org/10.1016/j.cmet.2016.04.011
Kwon H, Pessin JE (2013) Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) 4:71. https://doi.org/10.3389/fendo.2013.00071
Shehzad A, Iqbal W, Shehzad O, Lee YS (2012) Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens) 11:8–20
Kimlin LC, Casagrande G, Virador VM (2013) In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog 52:167–182. https://doi.org/10.1002/mc.21844
Sultana R, Kataki AC, Borthakur BB et al (2017) Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India. Gene 621:51–58. https://doi.org/10.1016/j.gene.2017.04.021
Gyamfi J, Eom M, Koo J-S, Choi J (2018) Multifaceted roles of Interleukin-6 in adipocyte–breast cancer cell interaction. Transl Oncol 11:275–285. https://doi.org/10.1016/J.TRANON.2017.12.009
Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI et al (2015) The role of cytokines in breast cancer development and progression. J Interf Cytokine Res 35:1–16. https://doi.org/10.1089/jir.2014.0026
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA (2016) Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 34:4270. https://doi.org/10.1200/JCO.2016.67.4283
Pileczki V, Braicu C, Gherman C, Berindan-Neagoe I (2012) TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis. Int J Mol Sci 14:411–420. https://doi.org/10.3390/ijms14010411
Li J, Han X (2018) Adipocytokines and breast cancer. Curr Probl Cancer 42(2):208–214. https://doi.org/10.1016/j.currproblcancer.2018.01.004
Dusaulcy R, Rancoule C, Grès S et al (2011) Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res 52:1247–1255. https://doi.org/10.1194/jlr.M014985
Choi J, Cha YJ, Koo JS (2018) Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog Lipid Res 69:11–20
Christopoulos PF, Msaouel P, Koutsilieris M et al (2015) The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer 14:43. https://doi.org/10.1186/s12943-015-0291-7
Creighton CJ, Casa A, Lazard Z et al (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast Cancer prognosis. J Clin Oncol 26:4078–4085. https://doi.org/10.1200/JCO.2007.13.4429
Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915–928. https://doi.org/10.1038/nrc2536
Edakuni G, Sasatomi E, Satoh T et al (2001) Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int 51:172–178
Bell LN, Ward JL, Degawa-Yamauchi M et al (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Metab 291:E843–E848. https://doi.org/10.1152/ajpendo.00174.2006
Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:297–308. https://doi.org/10.1016/j.ccr.2012.02.014
Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogene 5:e189. https://doi.org/10.1038/oncsis.2015.49
Vander Heiden M, Cantley L, Thompson C (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033. https://doi.org/10.1126/science.1160809
Pavlides S, Whitaker-Menezes D, Castello-Cros R et al (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8:3984–4001. https://doi.org/10.4161/cc.8.23.10238
Martinez-Outschoorn UE, Pestell RG, Howell A et al (2011) Energy transfer in “parasitic” cancer metabolism: mitochondria are the powerhouse and Achilles’ heel of tumor cells. Cell Cycle 10:4208–4216. https://doi.org/10.4161/cc.10.24.18487
Fadaka A, Ajiboye B, Ojo O et al (2017) Biology of glucose metabolization in cancer cells. J Oncol Sci 3:45–51. https://doi.org/10.1016/J.JONS.2017.06.002
Gupta S, Roy A, Dwarakanath BS (2017) Metabolic cooperation and competition in the tumor microenvironment: implications for therapy. Front Oncol 7:68. https://doi.org/10.3389/fonc.2017.00068
Balaban S, Shearer RF, Lee LS et al (2017) Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab 5:1. https://doi.org/10.1186/s40170-016-0163-7
Santos CR, Schulze A (2012) Lipid metabolism in cancer. FEBS J 279:2610–2623. https://doi.org/10.1111/j.1742-4658.2012.08644.x
Fagone P, Jackowski S (2009) Membrane phospholipid synthesis and endoplasmic reticulum function. J Lipid Res 50(Suppl):S311–S316. https://doi.org/10.1194/jlr.R800049-JLR200
Pascual G, Avgustinova A, Mejetta S et al (2017) Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541:41–45. https://doi.org/10.1038/nature20791
Lazar I, Clement E, Dauvillier S et al (2016) Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer. Cancer Res 76:4051–4057. https://doi.org/10.1158/0008-5472.CAN-16-0651
Ojima K, Oe M, Nakajima I et al (2016) Dynamics of protein secretion during adipocyte differentiation. FEBS Open Bio 6(8):816–826
Sun K, Tordjman J, Clément K, Scherer PE (2013) Fibrosis and adipose tissue dysfunction. Cell Metab 18:470–477. https://doi.org/10.1016/j.cmet.2013.06.016
Mariman EC, Wang P (2010) Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 67:1277–1292
Iyengar P, Espina V, Williams TW et al (2005) Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115:1163–1176. https://doi.org/10.1172/JCI23424
Park J, Scherer PE (2012) Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 122:4243–4256. https://doi.org/10.1172/JCI63930
Jia L, Wang S, Cao J et al (2007) siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes. Int J Biochem Cell Biol 39:2049–2062. https://doi.org/10.1016/j.biocel.2007.05.023
WHO (2016) Obesity and overweight. World Health Organization Fact sheet
Finkelstein EA, Khavjou OA, Thompson H et al (2012) Obesity and severe obesity forecasts through 2030. Am J Prev Med 42:563–570. https://doi.org/10.1016/j.amepre.2011.10.026
Smith KB, Smith MS (2016) Obesity statistics. Prim Care 43:121–135
Ramos Chaves M, Boléo-Tomé C, Monteiro-Grillo I et al (2010) The diversity of nutritional status in cancer: new insights. Oncologist 15:523–530. https://doi.org/10.1634/theoncologist.2009-0283
Gioulbasanis I, Martin L, Baracos VE et al (2015) Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense? Ann Oncol 26:217–221. https://doi.org/10.1093/annonc/mdu501
Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635. https://doi.org/10.1007/s10549-010-0990-0
Chan DS, Norat T (2015) Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Options in Oncol 16:22. https://doi.org/10.1007/s11864-015-0341-9
Ewertz M, Jensen M-B, Gunnarsdóttir KÁ et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29:25–31. https://doi.org/10.1200/JCO.2010.29.7614
Pierobon M, Frankenfeld CL (2013) Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 137:307–314. https://doi.org/10.1007/s10549-012-2339-3
James FR, Wootton S, Jackson A et al (2015) Obesity in breast cancer--what is the risk factor? Eur J Cancer 51:705–720. https://doi.org/10.1016/j.ejca.2015.01.057
Donohoe CL, Doyle SL, Reynolds JV (2011) Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 3:12
Schapira DV, Clark RA, Wolff PA et al (1994) Visceral obesity and breast cancer risk. Cancer 74:632–639. https://doi.org/10.1002/1097-0142(19940715)74:2<632::AID-CNCR2820740215>3.0.CO;2-T
Osman M, Hennessy B (2015) Obesity correlation with metastases development and response to first-line metastatic chemotherapy in breast cancer. Clin Med Insights Oncol 9:105–112. https://doi.org/10.4137/CMO.S32812
Tseng LM, Hsui CN, Chen SC et al (2013) Distant metastasis in triple-negative breast cancer. Neoplasma 60:290–294. https://doi.org/10.4149/neo_2013_038
Morris EV, Edwards CM (2016) The role of bone marrow adipocytes in bone metastasis. J Bone Oncol 5:121–123. https://doi.org/10.1016/j.jbo.2016.03.006
Chkourko Gusky H, Diedrich J, MacDougald OA, Podgorski I (2016) Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes Rev 17:1015–1029. https://doi.org/10.1111/obr.12450
Rausch LK, Netzer NC, Hoegel J, Pramsohler S (2017) The linkage between breast cancer, hypoxia, and adipose tissue. Front Oncol 7:211. https://doi.org/10.3389/fonc.2017.00211
Seo BR, Bhardwaj P, Choi S et al (2015) Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med 7:301ra130. https://doi.org/10.1126/scitranslmed.3010467
Templeton ZS, Lie W-RR, Wang W et al (2015) Breast cancer cell colonization of the human bone marrow adipose tissue niche. Neoplasia 17:849–861. https://doi.org/10.1016/j.neo.2015.11.005
Maller O, Martinson H, Schedin P (2010) Extracellular Matrix Composition Reveals Complex and Dynamic Stromal-Epithelial Interactions in the Mammary Gland. J Mammary Gland Biol Neoplasia 15:301–18. https://doi.org/10.1007/s10911-010-9189-6
Duval K, Grover H, Han L-H et al (2017) Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda) 32:266–277. https://doi.org/10.1152/physiol.00036.2016
Kenny PA, Lee GY, Myers CA et al (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1:84–96. https://doi.org/10.1016/j.molonc.2007.02.004
Ravi M, Paramesh V, Kaviya SR et al (2015) 3D cell culture systems: advantages and applications. J Cell Physiol 230:16–26. https://doi.org/10.1002/jcp.24683
Baker BM, Chen CS (2012) Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125:3015–3024. https://doi.org/10.1242/jcs.079509
Luca AC, Mersch S, Deenen R et al (2013) Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 8:e59689. https://doi.org/10.1371/journal.pone.0059689
Aljitawi OS, Li D, Xiao Y et al (2014) A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells. Leuk Lymphoma 55:378–391. https://doi.org/10.3109/10428194.2013.793323
Fang Y, Eglen RM (2017) Three-dimensional cell cultures in drug discovery and development. SLAS Discov 22:456–472. https://doi.org/10.1177/1087057117696795
Pallegar NK, Garland CJ, Mahendralingam M et al (2018) A novel 3-dimensional co-culture method reveals a partial mesenchymal to epithelial transition in breast cancer cells induced by adipocytes. J Mammary Gland Biol Neoplasia 24(1):85–97. https://doi.org/10.1007/s10911-018-9420-4
Bidarra SJ, Oliveira P, Rocha S et al (2016) A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion. Sci Rep 6:27072. https://doi.org/10.1038/srep27072
Seyfried TN, Huysentruyt LC (2013) On the origin of cancer metastasis. Crit Rev Oncog 18:43–73
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pallegar, N.K., Christian, S.L. (2020). Adipocytes in the Tumour Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1234. Springer, Cham. https://doi.org/10.1007/978-3-030-37184-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-37184-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37183-8
Online ISBN: 978-3-030-37184-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)